RxDoctor Payments Data

Laila Nooruddin

Family · Houston, TXNPI 1063731941

Payments from drug & device makers

$5,023in general payments, 2019–2025

Across 227 payments — averaging $22.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$973
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$651
  • Johnson & Johnson$560
  • Takeda Pharmaceuticals U.S.A., Inc.$341
  • Regeneron Healthcare Solutions, Inc.$302
  • Janssen Scientific Affairs, LLC$274
  • plus $2K from 20 others

What the payments were for

  • Food & beverage$4,82096%
  • Education$2034%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,023 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Medicare billing

Part B allowed, 2024
$51,266
Medicare patients
457
Services billed
519

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mesalamine15$10,686
Sucralfate23$2,668
Omeprazole170$2,514
Pantoprazole Sodium175$1,553
Esomeprazole Magnesium32$912
Lubiprostone14$645
Famotidine47$492
Dicyclomine Hcl21$364
Hydrocortisone22$195
Amitriptyline Hcl12$110

Paid to pharmacies, not to this prescriber.

Other family in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →